MIR2681

Across TCGA pan-cancer cohorts, MIR2681 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated MIR2681 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher MIR2681 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR2681 expression acts as an unfavorable survival marker.

OV, DLBC, and LIHC are the cancer types where MIR2681 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Tertile	II,III,IV	0.644	0.846	.003	90	view →
DLBC	DFS	Tertile	All	0.426	0.841	.018	63	view →
LIHC	DFS	Tertile	All	0.085	0.555	.001	54	view →
HNSC	OS	Tertile	II,III,IV	0.295	0.653	.018	27	view →
THYM	OS	Tertile	All	0.381	0.879	.003	24	view →
KIRP	OS	Tertile	II,III,IV	0.216	0.771	.049	9	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

MIR2681–OV (OS)

Open the OV breakdown →